| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 2 | |
| #2 | Australia | 1 | |
| #3 | Brazil | 1 | |
| #4 | Canada | 1 | |
| #5 | China | 1 | |
| #6 | EPO (European Patent Office) | 1 | |
| #7 | Israel | 1 | |
| #8 | Republic of Korea | 1 | |
| #9 | Mexico | 1 | |
| #10 | Singapore | 1 | |
| #11 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Biotechnology | |
| #2 | Pharmaceuticals | |
| #3 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Measuring microorganism processes | |
| #3 | Therapeutic chemical compounds | |
| #4 | Medical preparations | |
| #5 | Analysing materials |
| # | Name | Total Patents |
|---|---|---|
| #1 | Sirard Cynthia A | 6 |
| #2 | Kagey Michael H | 6 |
| #3 | Kagey Michael | 3 |
| #4 | Sirard Cynthia | 3 |
| #5 | Cynthia A Sirard | 2 |
| #6 | Michael H Kagey | 2 |
| #7 | Naik Girish | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2021055789A1 | Use of dkk-1 inhibitors for treating cancer | |
| EP3532099A1 | Use of beta-catenin as a biomarker for treating cancers using anti-dkk-1 antibody |